As of March 2023 Mesoblast has a market cap of $0.45 Billion. This makes Mesoblast the world's 5424th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $0.45 B | 4.08% |
2022 | $0.43 B | -33.91% |
2021 | $0.66 B | -34.9% |
2020 | $1.01 B | 30.05% |
2019 | $0.78 B | 92.31% |
2018 | $0.40 B | -24.07% |
2017 | $0.53 B | 36.85% |
2016 | $0.39 B | -23.6% |
2015 | $0.51 B | -56.03% |
2014 | $1.16 B | -28.73% |
2013 | $1.63 B | 69.86% |
2012 | $0.96 B | -11.09% |
2011 | $1.08 B | 47.28% |
2010 | $0.73 B | 341.55% |
2009 | $0.16 B | 99.5% |
2008 | $83.38 M |
On Mar 25th, 2023 the market cap of Mesoblast was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Nymox Pharmaceutical NYMX | $35.86 M | -92.12% | Bahamas |
![]() NRC Health
NRC | $1.10 B | 143.35% | ๐บ๐ธ USA |